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Abstract 
Objectives: Hypertension (HTN), obesity and low cardiorespiratory fitness (CRF) are associated 
with an increased risk of a cardiovascular event. Taking part overweight/obese individuals with 
HTN the aims of the current study were: to estimate cardiovascular risk (CVR) and vascular age 
(VA) profiles analyzing potential sex differences; to determine whether VA is higher than 
chronological age (CA) and, whether CVR is associated with a low level of CRF. 
Methods: Overweight/obese non-Hispanic white participants (n=209; 141 men and 68 women) 
with primary HTN had their CVR and VA determined using the New Pooled Cohort Risk 
Equations and The Framingham method, respectively. Considering values of peak oxygen 
uptake, participants were divided into tertiles for each sex. 
Results: The CVR, but not VA (p=0.339), was higher (p<0.001) in men compared to women 
irrespective of age. Irrespective of sex VA was higher than CA (p<0.001). Age and body mass 
index were higher (p<0.05) in the low CRF group compared to other groups. There were no 
differences in CVR (p=0.907) and VA (p=1.643) when values were separated into CRF groups. 
Conclusions: Pooled Cohort Equations could underestimate the risk of suffering a 
cardiovascular event in the following 10 years in overweight/obese non-Hispanic white women 
with HTN compared to men. The VA appears to be a useful tool in communicating CVR in this 
population irrespective of sex. The CRF alone may not be enough to moderate the CVR. 
Trial Registration: NCT02283047 
Keywords: Cardiovascular disease; Chronological age, Cardio-respiratory fitness. 
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Introduction 
Cardiovascular disease (CVD) is the leading cause of early morbidity and hospitalization in the 
world [1]. According to World Health Organization 17.5 million people died from CVD in 2012, 
representing 31% of all deaths, of which 7.4 and 6.7 million were due to coronary heart 
disease and cardiovascular (CV) events, respectively [2]. Furthermore, a large number of 
individuals have a heightened risk of CVD because they have two or more associated risk 
factors [1,3,4]. 
Several attempts have been made to determine CV risk (CVR) factors associated with having a 
cardiac event. Guidelines indicate that age, sex, diabetes, smoking, cholesterol and 
hypertension (HTN) have a causal relationship with CV events and premature death [1,3,5]. 
High blood pressure (BP), often referred to as HTN, is the most common CVR factor which 
leads to heart failure, stroke, angina and premature death if not detected early and treated 
adequately [6]. Additionally, population based research suggest that obesity is directly related 
to HTN [7]. An appreciation of the clinical significance of obesity-related HTN has since grown 
substantially over time. As such, obesity is now recognized as a major cause of HTN (at least 
75% of all cases) and the combination of both are well known to increase CVR [7]. Additionally, 
CVR factors, associated with the development of CVD, are similar in both sexes [8]. However, 
with the same risk factors, CVR is two to five times more common in men than in women, i.e. 
women have a lower predicted 10-year risk [9]. It has previously been suggested that this 
discrepancy may be due to the protective action of estrogens [8] or because substantial 
disparities exist in the prevention, recognition, management and clinical outcomes of CVD in 
women [10]. A CVR score can be used to determine CVD using the Pooled Cohort Equations 
and the Framingham Heart Study which are tools commonly used to define the 10-year risk of 
developing CVD [9]. An additional tool for evaluating the overall CVR is vascular age (VA). This 
is a quite novel concept derived from Framingham CVR tables, which indicates the biological 
age of aŶ iŶdiǀidual’s arteries (i.e., the age of the vascular system of a person with different 
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CVR factors) [1,11]. This process is accelerated with the presence of additional CVR factors and 
is associated with changes in the mechanical and the structural properties of the vascular wall, 
which leads to poor endothelial health and the loss of arterial elasticity [1,7]. 
The relationship between poor lifestyle and increased CVR is well documented. As such there 
is a persistent need to discuss cardio metabolic lifestyle factors with all patients, in order to 
reduce CVD, and control the CVR factors. Cardiovascular risk factors can be classified as 
modifiable and non-modifiable. Non-modifiable risk factors are (but not limited to) age, sex 
and family history. Modifiable CVR factors are cardio metabolic lifestyle factors and can be 
altered during the cause of one life; these include but are not limited to smoking, alcohol, diet 
and importantly physical activity [12]. Higher levels of physical activity can improve the CVR in 
diseased or at risk patients. Cardio-respiratory fitness (CRF) can be used to quantify these 
positive effects as it is negatively associated with a reduction in CV morbidity and mortality 
[12]. 
Currently, there is no known research that measures CVR and VA and its association with CRF 
in primary hypertensive and overweight/obese adults. Considering the importance of CVR 
factors and the limited scientific literature, the aims of the study were: 1) to estimate CVR and 
VA profiles of overweight/obese patients with HTN, analyzing potential sex differences, (2) to 
determine whether VA is higher than chronological age (CA) and, (3) to determine whether 
CVR is associated with a low level of CRF. 
Methods 
Study design 
Baseline data from EXERDIET-HTA randomized controlled experimental trial were taken for the 
purpose of this study [13]. The design, selection criteria and procedures for the EXERDIET-HTA 
study have been previously detailed [13]. The study protocol was approved by The Ethics 
Committee of The University of the Basque Country (UPV/EHU, CEISH/279/2014) and the 
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Ethics Committee of Clinical Investigation of Araba University Hospital (2015-030), and all 
participants provided written informed consent prior to any data collection. 
Participants 
Non-Hispanic white participants (n=209) with primary HTN ;шϭϰϬ “ǇstoliĐ BP ;“BPͿ aŶd ш90 
diastolic BP) [4], who were classified as being overweight ;ďodǇ ŵass iŶdeǆ, BMIшϮϱͿ or obese 
;BMIшϯϬͿ [14] were recruited from the cardiology services and local media. . 
Cardio-respiratory fitness 
Cardio-respiratory fitness was determined using a cardiopulmonary exercise test to assess 
V̇O2peak. Briefly, the test was performed on an electronically braked Lode Excalibur Sport Cycle 
Ergometer (Groningen, The Netherlands). The testing protocol was started at 40W (70 rpm) 
with gradual increments of 10W every minute until exhaustion with continuous 
electrocardiogram monitoring. Expired gas analysis was determined using a commercially 
available metabolic cart (Ergo CardMedi-soft S.S, Belgium Ref. USM001 V1.0) which was 
calibrated before each test with a standard gas of known concentration and volume. Breath 
by-breath data were measured continuously during exercise before being averaged over each 
60 second periods. Blood pressure was measured every two minutes throughout the test. At 
the end of each stage the rate of perceived exertion (6 to 20) was recorded (Borg Scale). Peak 
oxygen uptake was defined as the highest oxygen uptake value attained toward the end of the 
test. Achievement of V̇O2peak was assumed with the presence of two or more of the following 
criteria: 1) volitional fatigue (>18 on Borg scale), 2) peak respiratory exchange ratio (V̇CO2/V̇O2) 
шϭ.ϭ, ϯͿ achieving >85% of age predicted maximum heart rate, aŶd ϰͿ failure of V̇O2 and/or 
heart rate to increase with further increases in work rate [13]. 
The distributions of V̇O2peak were divided into tertiles for each sex: The lowest tertile (Low-CRF 
group); V̇O2peak ч21 in men aŶd V̇O2peak чϭϲ iŶ women; the intermediate tertile (Medium-CRF 
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group); 21.1<V̇O2peak ч26 in men and 16.1<V̇O2peakч21 in women and the highest tertile (High-
CRF group); V̇O2peak>26 in men aŶd V̇O2peak>21 mL·kg·min-1 in women. 
Measurement of CVD Risk Factors 
Established CVR factors used in the present study to determine the CVR and VA of participants 
were defined as follows: 
Blood pressure. Ambulatory BP monitoring was conducted over a 24 hour period using an 
oscillometric ABPM 6100 recorder (Welch Allyn, New York, USA) to evaluate SBP (as used to 
determine CVR) [9]. The device was used in line with the recommendations set by the ESH/ESC 
guidelines. As such BP was measured at 30-minute intervals during the awake-time and at 60-
minute intervals during periods of sleep. Data were only used if at least 75% of the awake-time 
and sleep periods were successfully recorded [13]. 
Blood sampling. Fasting venous blood (12.5ml) was obtained from each participant. Diabetes 
mellitus (DM) was defined as a fasting glucose of шϭϮϲ ŵg/dL. Additionally, measurements of 
glucose and lipid profile (total-, HDL- and LDL-cholesterol) were assayed.  
Self report. Age and cigarette smoking status were assessed by self-report. All medicines were 
ascertained from the partiĐipaŶt’s physician. 
Cardiovascular risk. The Framingham Heart Study is a quantitative method used in primary 
care for assessment of general CVR profile. The absolute risk applies to the individual, a score 
of 10% means that there is a 10% chance of having a CV event within the next 10 years [9,11]. 
Under 6% is considered low risk; between 6 aŶd ϮϬ% ŵediuŵ risk, aŶd шϮϬ% high risk [11]. 
Recently, New Pooled Cohort Risk Equations have been developed from the Framingham Heart 
Study [9,11]. The equation to estimate the 10-year risk of developing a first atherosclerotic 
CVD event were developed from sex- and race-specific proportional-hazard models that 
included the covariates of age, treated or untreated high SBP level, total cholesterol and HDL-C 
concentrations, current smoking status, and history of DM. For the equation, the values for 
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age, lipids, and SBP were log transformed. Interactions between age and lipids or age and SBP 
used the natural log of each variable. Calculation of the 10-year risk estimate for hard 
atherosclerotic CVD is described as a series of steps [9]. 
Vascular age. The Framingham method was used to determine the VA of all participants [11]. 
The VA indicates the biological age of the iŶdiǀidual’s ǀasĐular system, as the age a person 
would be with the same calculated CVR but whose risk factors were all within normal ranges. 
The sex specific risk factors considered were age, HDL-C, total cholesterol, SBP, DM and 
smoking status. Each variable received a weighted score; the sum of the score for each variable 
was then translated to the risk of a CV event in 10 years and the VA [11]. 
Statistical analysis 
Descriptive statistics were calculated for all variables. Data are expressed as mean±standard 
deviations (SD). All variables were deemed normally distributed using a Kolmogorov-Smirnov 
apart from, age, total cholesterol, HDL-C, CVR and VA which had a skewed distribution and 
were therefore log transformed prior to any analysis. 
A 2 sample t-test was used to determine whether there was a significant sex difference for the 
variables: age, BMI, SBP, total cholesterol, HDL-C, antihypertensive medication, cigarette 
smoking and DM. Analysis of covariance (ANCOVA) was used to examine the dependant 
variables (age, BMI, SBP, total cholesterol, HDL-C, antihypertensive medication, cigarette 
smoking, DM, CVR and VA) of the participants classified by CRF level (low, medium and high). A 
Bonferroni test was used to determine the level of significance when a significant main effect 
was found. Statistical significance was set at p<0.05. The statistical analyses were performed 
with the SPSS version 22.0 software package. 
Results 
The characteristics of CVR factors classified by sex are presented in Table 1. The mean age 
(SD) of participants was 54.0±8.1 yrs with 67.5% and 32.5% being men and women, 
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respectively. All participants were classified as obese (BMI>30 kg/m2) in accordance with 
AHA/ACC/TOS guidelines for the Management of Overweight and Obesity in Adults [14]. 
Although 87.1% of all participants were taking anti-hypertensive medication, mean SBP 
suggested that all participants irrespective of sex were pre-hypertensive. However, there was a 
trend to suggest that women had a lower SBP compared to men (mean difference=1.6; 95%, 
confidence interval (CI)=-2.5-5.7 mmHg). Mean total cholesterol was similar in men and 
women with both sexes exceeding cut-off values set by the ESH/ESC guidelines [4], but there 
was also a trend to suggest that women had lower total cholesterol than men (mean 
difference=3.3; 95% CI=-30.6-37.3 mmHg). Moreover, HDL-C was significantly higher (p=0.002) 
in women than men (mean difference=5.0, 95% CI=-13.3-3.3 mg/dL), but both were inside the 
healthy cut-off values suggested by the ESH/ESC guidelines [4]. Smoking was present 11.4% of 
the participants and 4.5% of the sample was suffering from DM. 
The absolute CVR was significantly different (p<0.001) between sexes with women having a 
lower CVR than men (mean difference 5.8, 95% CI=-3.8-7.7 %, Table 1). Additionally, in 
accordance with the Framingham study and ACC/AHA Guideline on the Assessment of CVR 
[9,11] men were considered to be at medium risk whereas women were considered low risk. 
As shown in Table 2, there were no sex differences in VA (mean difference=1.4, 95% CI=-2.4-
5.1 yrs). However, VA was significantly higher (p=0.001) than CA (mean difference=8.8, 95% 
CI=7.2-10.3 yrs). 
Characteristics of the participants separated into CRF groups are presented in Table 3. 
Bonferroni analysis revealed that age was higher (p<0.05, Δ=-9.7%) in the low CRF group 
compared to the high CRF group. Moreover, BMI was higher in the low CRF group compared to 
the medium CRF group (34.0±0.5 vs. 31.2±0.5 kg/m2; mean difference=2.8, 95% CI=1.1-4.4 
kg/m2) and to the high CRF group (34.0±0.5 vs. 28.5±0.5 kg/m2; mean difference=5.5, 95% 
CI=3.8-7.2 kg/m2). No significant differences were observed among CRF groups for SBP, total 
cholesterol, antihypertensive medication, smoking, DM or HDL-C (p>0.05). 
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Bonferroni analysis revealed that no significant differences were observed in CVR (p=0.907) 
and VA (p=1.643), when values were separated into CRF groups (Table 3). However, the low 
CRF group showed an upward trend in VA with higher values than those with medium CRF 
group (mean difference=0.5, 95% CI=-4.1-5.0 yrs) or higher CRF group (mean difference=3.4, 
95% CI=-1.5-8.4 yrs). 
Discussion 
To our knowledge this is the first known study to estimate the CVR and VA in 
overweight/obese people with HTN and its association with CRF level using the recently 
developed Pooled Cohort Equations [9] and the original 2008 Framingham model. The main 
findings of this study were: 1) CVR is significantly higher in men than in women despite them 
having same CVR values and this is not effected by age; 2) predicted VA is significantly higher 
than CA in overweight/obese people with primary HTN with no sex differences, and 3) CRF 
alone did not appear to significantly moderate CVD. These findings highlight the importance of 
being able to determine the CVR and VA of overweight/obese people with primary HTN. 
Considering the known increase in CVD in hypertensive patients and the relative ease of 
predicting 10-year CVR; defining CVR and VA in a hypertensive population would likely be a 
useful tool for clinicians. 
Although the role of major CVR factors in the development of CVD and VA were similar in both 
sexes, Table 1 shows that CVR is 57% higher in men than in women (p=0.001), with an 
estimated 10-year risk of hard atherosclerotic CVD event of 10% in men and 4.3% in women, 
which represents medium and low risk, respectively. As such, it is likely that men have a higher 
risk of suffering a CV event in the following 10 years. The difference in the HDL-C level could be 
one of the determinants of the sex difference in CVR profile in the present study, with women 
showing higher concentrations compared to men. It is well known that high concentrations of 
HDL-C prevent the development of atherosclerosis and CVD. In particular, the transport of 
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reserve cholesterol and the inhibition of oxidized LDL-induced monocyte infiltration can avoid 
this development [15]. In addition, the Framingham Heart Study showed that HDL-C was the 
most powerful lipid predictor of CHD risk in both sexes >49 yr old. For every 1mg/dL increment 
in HDL-C, there was an associated 2% decreased in the risk of CHD in men, and a 3% decrease 
in women [16]. Previous studies have shown that the increased CVR in men was hidden behind 
an almost-normal classic lipid profile, being total cholesterol, LDL-C, and TG higher, and HDL-C 
concentrations significantly lower than women (pre or post menopausal status), with all values 
within the normal range [17]. In our study, both sexes presented hyperlipidemia values (total 
cholesterol>190mg/dL) and prehypertensive SBP values with slight, but concomitant variation 
(i.e., an upward trend in men compared to women), which has been shown to increase the risk 
of coronary heart disease and promotes a poor cardio metabolic profile [17]. It seems that 
there is a cardio protective effect of endogenous estrogens in premenopausal women, when 
compared with age-matched men, due to an enhanced HDL quality. However, in 
postmenopausal women there is a trend to present with a significantly increased BMI, BP, LDL-
C and total cholesterol, along with a reduction of absolute HDL-C concentration, with changes 
in the composition of HDL particles [17,18]. In the present study, 51.5% of women were 
premenopausal state. Therefore, it should take into account that in the current study: 1) both 
men and women were in normal HDL-C values (>40 mg/dL for men, and >46 mg/dL for 
women) [4], along with obesity, hyperlipidemia and primary HTN diagnostic, 2) almost half of 
the women were on postmenopausal state and 3) the sex-specific risk prediction model used 
in the Pooled Cohort Equation always calculates a higher risk in men compared to women, 
despite them having same CVR values and regardless of age [9]. As such, women could show 
an underestimated CVR profile with less aggressive treatment strategies. Nowadays, a greater 
number of women die annually from CVD compared with men [19]. Thus, although sex 
differences are well documented in the prevalence of the CVR factors, the clinical 
manifestation and incidence of CVD and the impact of risk factors on outcomes [20] in women 
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is often underestimated due to the ŵisperĐeptioŶ that feŵales are ͞proteĐted͟ agaiŶst CVD 
[21]. 
As expected, VA was significantly higher (p=0.001) than CA (Table 2) (VA=62 vs. CA=54 yrs). As 
such, people with primary HTN and obesity are ͞older͟ for their VA ǁheŶ Đoŵpared ǁith their 
CA. It is, therefore, likely that the health of the heart and blood vessels are more deteriorated 
than they should be in this population [11]. There is good evidence that CA is strongly and 
independently related to CVR, but this is not necessarily so for the VA. Repeated exposure to 
CVR factors across the lifespan leads to between-subject differences in VA and CA [22]. 
Previous research has shown that in apparently healthy and asymptomatic people, 72.45% of 
the individuals had a greater VA than the CA, suggesting that this risk may be underestimated 
[23]. The current study suggests that key contributors of an increased VA in a hypertensive 
population are dyslipidemia, SBP, treatment for HTN, obesity and smoking (87.2% of them 
showing a greater VA than CA). Thus, VA seems to be a useful tool in communicating about risk 
to individuals, such as hypertensive and obese patients, who are at a greater risk of a CVD 
event, and warrant early intervention of modifiable CVR factors (i.e., healthy eating, increasing 
physical activity, cessation of cigarette smoking and alcohol). 
It is well recognized that physical activity is an important factor for reducing CVR and CVD 
[9,12]. Previous research has suggested that people with sedentary behaviors are at a higher 
risk of all-cause mortality compared with those who do at least 150 minutes of moderate-
intensity, or 75 minutes of vigorous-intensity aerobic physical activity per week, as 
recommended by WHO [12]. In the current study it was found that CRF alone does not 
significantly moderate CVR, due to no differences among three CRF groups (Table 3). However, 
mean difference and CI suggest that those who are in the low CRF group, have meaningfully 
higher VA (although no significant) (Table 3); which suggests that CVR may in-part be 
moderated by CRF but in conjunction with other CVR factors such as BMI and age. Aging and 
inactivity are associated with a decrease in both CRF and morphological changes in all layers of 
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the vascular tree, and these are accompanied by increased arterial stiffness and aortic 
pressure, leading to a higher VA [24]. Furthermore, in the present study BMI explained the 
22.5% and age 6% of the variance between the CRF groups. The current study reinforces the 
evidence linking obesity, age and CRF level with VA in primary hypertensive population [7,25], 
suggesting that low CRF could potentially be used in conjunction with other CVR factors to help 
determine predisposal of CVD, but not as a factor in its own right. Previous studies have 
concluded that physical activity is associated with beneficial changes in circulating lipids and 
lipoproteins, body weight, BP and insulin sensitivity, having a significant reduction in CVR 
[12,25]. In line with that, the last 2016 European Guidelines on CVD prevention in clinical 
practice highlight the CRF as a factor that might influence the relationship between adiposity 
aŶd ĐliŶiĐal progŶosis iŶ the ͞oďesitǇ paradoǆ͟. Thus, Ŷorŵal ǁeight iŶdiǀiduals with a low CRF 
have a higher risk of mortality than fit individuals, regardless of their BMI [1,26]. 
Although our study has highlighted the importance of determining CVR factors in a 
hypertensive population, several limitations should be acknowledged. Firstly, although our 
sample size was sufficient as an initial investigation into CVR and HTN; it would not be 
comparable with that of larger epidemiological studies and future studies should consider 
large scale investigations as well as determining the short and long-term effects of different 
interventions. Secondly, the current study only had 32.5% of women which does not represent 
an equal gender split. As this poses statistical issues, future studies, particularly those using 
interventions should look to recruit equal numbers. Lastly, although CRF did not sufficiently 
moderate CVR in the current study, the effects of physical activity in a hypertensive patients 
with a broader range of V̇O2peak should be further investigated in conjunction with other 
modifiable risk factors to determine the effectiveness of moderating CVR and VA. Additionally, 
future studies should look to determine whether VA and CVR can be used to more easily 
inform patients of their cardiovascular health than current methods.  
Conclusions 
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Findings suggest that male non-Hispanic white overweight/obese individuals with diagnosed 
HTN have a higher risk of suffering a CV event in the following 10 years compared to females 
according to the greater CVR assessed using the Pooled Cohort Equations. However, CVR in 
women could be underestimated when both sexes present with the same CVR values and age. 
Those ǁho are oǀerǁeight/oďese ǁith HTN haǀe aŶ ͞older͟ VA compared to their CA 
irrespective of sex. Finally, although CRF alone did not moderate CVR in the current study, 
further research into the effect of physical activity alongside additional modifiable CVR factors 
in HTN populations, particularly those who are the least active is warranted. Predictions of CVR 
and VA estimation may represent as a useful clinical tool for detecting patients at risk of a 
cardiac event, but estimation equations should be more focused on sex related differences. 
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